tradingkey.logo

iRhythm Technologies Inc

IRTC

164.970USD

+24.790+17.68%
Close 08/01, 16:00ETQuotes delayed by 15 min
5.27BMarket Cap
LossP/E TTM

iRhythm Technologies Inc

164.970

+24.790+17.68%
More Details of iRhythm Technologies Inc Company
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Company Info
Ticker SymbolIRTC
Company nameiRhythm Technologies Inc
IPO dateOct 20, 2016
Founded at2006
CEOMr. Quentin S. Blackford
Number of employees2000
Security typeOrdinary Share
Fiscal year-endOct 20
Address699 8th Street
CitySAN FRANCISCO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code94103
Phone14156325700
Websitehttps://www.irhythmtech.com/
Ticker SymbolIRTC
IPO dateOct 20, 2016
Founded at2006
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
107.36K
+0.28%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
34.43K
-4.46%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
+7.94%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
17.70K
-14.49%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
16.45K
-3.73%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+13.46%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+14.39%
Ms. Karen K. Mcginnis, CPA
Ms. Karen K. Mcginnis, CPA
Independent Director
Independent Director
2.04K
--
Kevin O Boyle
Kevin O Boyle
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
107.36K
+0.28%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
34.43K
-4.46%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
+7.94%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
17.70K
-14.49%
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
16.45K
-3.73%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.56K
-10.16%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
83.80M
52.81%
Contracted third-party payors
83.80M
52.81%
Centers for Medicare & Medicaid
38.11M
24.02%
Healthcare Institutions
26.67M
16.81%
Non-contracted third-party payors
10.09M
6.36%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commercial Payors
83.80M
52.81%
Contracted third-party payors
83.80M
52.81%
Centers for Medicare & Medicaid
38.11M
24.02%
Healthcare Institutions
26.67M
16.81%
Non-contracted third-party payors
10.09M
6.36%
Shareholding Stats
Updated: Tue, May 20
Updated: Tue, May 20
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.71%
Sands Capital Management, LLC
9.45%
Artisan Partners Limited Partnership
8.82%
BlackRock Institutional Trust Company, N.A.
7.35%
Capital Research Global Investors
6.90%
Other
57.77%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
9.71%
Sands Capital Management, LLC
9.45%
Artisan Partners Limited Partnership
8.82%
BlackRock Institutional Trust Company, N.A.
7.35%
Capital Research Global Investors
6.90%
Other
57.77%
Shareholder Types
Shareholders
Proportion
Investment Advisor
71.97%
Investment Advisor/Hedge Fund
25.08%
Hedge Fund
8.05%
Research Firm
5.45%
Family Office
1.80%
Individual Investor
1.23%
Pension Fund
0.97%
Bank and Trust
0.85%
Sovereign Wealth Fund
0.45%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
580
36.48M
114.26%
-2.42M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
2023Q2
537
34.27M
112.49%
-3.29M
2023Q1
552
34.64M
113.74%
-3.49M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
3.10M
9.71%
-28.18K
-0.90%
Mar 31, 2025
Sands Capital Management, LLC
3.02M
9.45%
-160.50K
-5.05%
Mar 31, 2025
Artisan Partners Limited Partnership
2.81M
8.82%
+51.55K
+1.87%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.35M
7.35%
-27.32K
-1.15%
Mar 31, 2025
Capital Research Global Investors
2.20M
6.9%
+565.60K
+34.55%
Mar 31, 2025
Mackenzie Investments
1.16M
3.62%
-225.99K
-16.35%
Mar 31, 2025
State Street Global Advisors (US)
917.69K
2.87%
-31.09K
-3.28%
Mar 31, 2025
BNP Paribas Asset Management USA, Inc.
879.82K
2.76%
+19.00K
+2.21%
Mar 31, 2025
Champlain Investment Partners, LLC
822.79K
2.58%
+96.53K
+13.29%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.37K
2.35%
+18.90K
+2.58%
Mar 31, 2025
View more
Related ETFs
Updated: 3 hours ago
Updated: 3 hours ago
Name
Proportion
Global X HealthTech ETF
3.72%
BNY Mellon Innovators ETF
3.37%
Goldman Sachs Future Health Care Equity ETF
2.42%
Fidelity Digital Health ETF
2.26%
SPDR S&P Health Care Equipment ETF
1.91%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.49%
JPMorgan Fundamental Data Science Small Core ETF
1.05%
Langar Global HealthTech ETF
1.01%
First Trust Multi-Manager Small Cap Opportunities ETF
0.89%
View more
Global X HealthTech ETF
Proportion3.72%
BNY Mellon Innovators ETF
Proportion3.37%
Goldman Sachs Future Health Care Equity ETF
Proportion2.42%
Fidelity Digital Health ETF
Proportion2.26%
SPDR S&P Health Care Equipment ETF
Proportion1.91%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.61%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion1.49%
JPMorgan Fundamental Data Science Small Core ETF
Proportion1.05%
Langar Global HealthTech ETF
Proportion1.01%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.89%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI